Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - temozolomide 5mg;   - capsule - 5 mg - active: temozolomide 5mg   excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid tekprint black sw-9008 - temaccord capsules are indicated for the treatment of patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment.

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - dutasteride 0.5mg - soft gelatin capsule - 500 mcg - active: dutasteride 0.5mg excipient: butylated hydroxytoluene gelatin glycerol iron oxide red iron oxide yellow octanoic/decanoic acid glycerides titanium dioxide - terod is indicated for the treatment of, and to prevent progression of benign prostatic hyperplasia (bph) by reducing prostate size, alleviating symptoms, improving urinary flow and reducing the risk of acute urinary retention (aur) and the need for bph related surgery. terod is indicated for use as combination therapy in the management of symptomatic bph with an alpha blocker which is approved for use in bph and which has been dose titrated in accordance with the relevant recommendation in the product information for that alpha blocker.

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - codeine phosphate hemihydrate 15mg;   - tablet - 15 mg - active: codeine phosphate hemihydrate 15mg   excipient: lactose monohydrate magnesium stearate maize starch microcrystalline cellulose opadry white y-1r-7000b povidone purified water   sodium starch glycolate

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - codeine phosphate hemihydrate 30mg;   - tablet - 30 mg - active: codeine phosphate hemihydrate 30mg   excipient: lactose monohydrate magnesium stearate maize starch microcrystalline cellulose opadry white y-1r-7000b povidone purified water   sodium starch glycolate

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - codeine phosphate hemihydrate 60mg;   - tablet - 60 mg - active: codeine phosphate hemihydrate 60mg   excipient: lactose monohydrate magnesium stearate maize starch microcrystalline cellulose opadry white y-1r-7000b povidone purified water   sodium starch glycolate

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - pethidine hydrochloride 100mg;   - tablet - 100 mg - active: pethidine hydrochloride 100mg   excipient: lactose monohydrate magnesium stearate maize starch microcrystalline cellulose opadry white y-1r-7000b povidone purified water sodium starch glycolate

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - pethidine hydrochloride 50mg;   - tablet - 50 mg - active: pethidine hydrochloride 50mg   excipient: lactose monohydrate magnesium stearate maize starch microcrystalline cellulose opadry white y-1r-7000b povidone purified water sodium starch glycolate

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - clozapine 50 mg/ml;  ;   - oral suspension - 50 mg/ml - active: clozapine 50 mg/ml     excipient: glycerol hydrochloric acid monobasic sodium phosphate dihydrate povidone purified water sodium hydroxide sodium methyl hydroxybenzoate sodium propyl hydroxybenzoate sorbitol xanthan gum - the use of clozapine is indicated in the treatment of resistant schizophrenic patients only, i.e. schizophrenic patients who are non-responsive to or intolerant of classical antipsychotics. non-responsiveness is defined as a lack of satisfactory clinical improvement despite the use of adequate doses of at least two marketed antipsychotics prescribed for adequate durations. intolerance is defined as the impossibility of achieving adequate clinical benefit with classical antipsychotic drugs because of severe and untreatable neurological adverse reactions (extrapyramidal side effects or tardive dyskinesia).

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - clozapine 100mg;   - tablet - 100 mg - active: clozapine 100mg   excipient: lactose monohydrate magnesium stearate microcrystalline cellulose povidone purified water sodium starch glycolate - the use of clozapine is indicated in the treatment of resistant schizophrenic patients only, i.e. schizophrenic patients who are non-responsive to or intolerant of classical antipsychotics. non-responsiveness is defined as a lack of satisfactory clinical improvement despite the use of adequate doses of at least two marketed antipsychotics prescribed for adequate durations. intolerance is defined as the impossibility of achieving adequate clinical benefit with classical antipsychotic drugs because of severe and untreatable neurological adverse reactions (extrapyramidal side effects or tardive dyskinesia).

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - clozapine 200mg;   - tablet - 200 mg - active: clozapine 200mg   excipient: lactose monohydrate magnesium stearate microcrystalline cellulose povidone purified water sodium starch glycolate - the use of clozapine is indicated in the treatment of resistant schizophrenic patients only, i.e. schizophrenic patients who are non-responsive to or intolerant of classical antipsychotics. non-responsiveness is defined as a lack of satisfactory clinical improvement despite the use of adequate doses of at least two marketed antipsychotics prescribed for adequate durations. intolerance is defined as the impossibility of achieving adequate clinical benefit with classical antipsychotic drugs because of severe and untreatable neurological adverse reactions (extrapyramidal side effects or tardive dyskinesia).